Human embryonic stem cells for brain repair?

Su Chun Zhang, Xue Jun Li, Michael Johnson, Matthew T. Pankratz

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Cell therapy has been perceived as the main or ultimate goal of human embryonic stem (ES) cell research. Where are we now and how are we going to get there? There has been rapid success in devising in vitro protocols for differentiating human ES cells to neuroepithelial cells. Progress has also been made to guide these neural precursors further to more specialized neural cells such as spinal motor neurons and dopamine-producing neurons. However, some of the in vitro produced neuronal types such as dopamine neurons do not possess all the phenotypes of their in vivo counterparts, which may contribute to the limited success of these cells in repairing injured or diseased brain and spinal cord in animal models. Hence, efficient generation of neural subtypes with correct phenotypes remains a challenge, although major hurdles still lie ahead in applying the human ES cell-derived neural cells clinically. We propose that careful studies on neural differentiation from human ES cells may provide more immediate answers to clinically relevant problems, such as drug discovery, mechanisms of disease and stimulation of endogenous stem cells.

Original languageEnglish (US)
Pages (from-to)87-99
Number of pages13
JournalPhilosophical Transactions of the Royal Society B: Biological Sciences
Volume363
Issue number1489
DOIs
StatePublished - Jan 12 2008
Externally publishedYes

Fingerprint

embryonic stem cells
Stem cells
Brain
Repair
neurons
brain
Dopaminergic Neurons
Neurons
dopamine
Neuroepithelial Cells
Dopamine
Phenotype
Stem Cell Research
phenotype
Spinal Cord Diseases
Motor Neurons
cells
Drug Discovery
motor neurons
Cell- and Tissue-Based Therapy

Keywords

  • Cell therapy
  • Embryonic stem cells
  • Neural patterning
  • Neural transplantation
  • Neuroectoderm

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Human embryonic stem cells for brain repair? / Zhang, Su Chun; Li, Xue Jun; Johnson, Michael; Pankratz, Matthew T.

In: Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 363, No. 1489, 12.01.2008, p. 87-99.

Research output: Contribution to journalReview article

Zhang, Su Chun ; Li, Xue Jun ; Johnson, Michael ; Pankratz, Matthew T. / Human embryonic stem cells for brain repair?. In: Philosophical Transactions of the Royal Society B: Biological Sciences. 2008 ; Vol. 363, No. 1489. pp. 87-99.
@article{93f615195c764b388700e7ec20b5eb75,
title = "Human embryonic stem cells for brain repair?",
abstract = "Cell therapy has been perceived as the main or ultimate goal of human embryonic stem (ES) cell research. Where are we now and how are we going to get there? There has been rapid success in devising in vitro protocols for differentiating human ES cells to neuroepithelial cells. Progress has also been made to guide these neural precursors further to more specialized neural cells such as spinal motor neurons and dopamine-producing neurons. However, some of the in vitro produced neuronal types such as dopamine neurons do not possess all the phenotypes of their in vivo counterparts, which may contribute to the limited success of these cells in repairing injured or diseased brain and spinal cord in animal models. Hence, efficient generation of neural subtypes with correct phenotypes remains a challenge, although major hurdles still lie ahead in applying the human ES cell-derived neural cells clinically. We propose that careful studies on neural differentiation from human ES cells may provide more immediate answers to clinically relevant problems, such as drug discovery, mechanisms of disease and stimulation of endogenous stem cells.",
keywords = "Cell therapy, Embryonic stem cells, Neural patterning, Neural transplantation, Neuroectoderm",
author = "Zhang, {Su Chun} and Li, {Xue Jun} and Michael Johnson and Pankratz, {Matthew T.}",
year = "2008",
month = "1",
day = "12",
doi = "10.1098/rstb.2006.2014",
language = "English (US)",
volume = "363",
pages = "87--99",
journal = "Philosophical Transactions of the Royal Society B: Biological Sciences",
issn = "0800-4622",
publisher = "Royal Society of London",
number = "1489",

}

TY - JOUR

T1 - Human embryonic stem cells for brain repair?

AU - Zhang, Su Chun

AU - Li, Xue Jun

AU - Johnson, Michael

AU - Pankratz, Matthew T.

PY - 2008/1/12

Y1 - 2008/1/12

N2 - Cell therapy has been perceived as the main or ultimate goal of human embryonic stem (ES) cell research. Where are we now and how are we going to get there? There has been rapid success in devising in vitro protocols for differentiating human ES cells to neuroepithelial cells. Progress has also been made to guide these neural precursors further to more specialized neural cells such as spinal motor neurons and dopamine-producing neurons. However, some of the in vitro produced neuronal types such as dopamine neurons do not possess all the phenotypes of their in vivo counterparts, which may contribute to the limited success of these cells in repairing injured or diseased brain and spinal cord in animal models. Hence, efficient generation of neural subtypes with correct phenotypes remains a challenge, although major hurdles still lie ahead in applying the human ES cell-derived neural cells clinically. We propose that careful studies on neural differentiation from human ES cells may provide more immediate answers to clinically relevant problems, such as drug discovery, mechanisms of disease and stimulation of endogenous stem cells.

AB - Cell therapy has been perceived as the main or ultimate goal of human embryonic stem (ES) cell research. Where are we now and how are we going to get there? There has been rapid success in devising in vitro protocols for differentiating human ES cells to neuroepithelial cells. Progress has also been made to guide these neural precursors further to more specialized neural cells such as spinal motor neurons and dopamine-producing neurons. However, some of the in vitro produced neuronal types such as dopamine neurons do not possess all the phenotypes of their in vivo counterparts, which may contribute to the limited success of these cells in repairing injured or diseased brain and spinal cord in animal models. Hence, efficient generation of neural subtypes with correct phenotypes remains a challenge, although major hurdles still lie ahead in applying the human ES cell-derived neural cells clinically. We propose that careful studies on neural differentiation from human ES cells may provide more immediate answers to clinically relevant problems, such as drug discovery, mechanisms of disease and stimulation of endogenous stem cells.

KW - Cell therapy

KW - Embryonic stem cells

KW - Neural patterning

KW - Neural transplantation

KW - Neuroectoderm

UR - http://www.scopus.com/inward/record.url?scp=36448935660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448935660&partnerID=8YFLogxK

U2 - 10.1098/rstb.2006.2014

DO - 10.1098/rstb.2006.2014

M3 - Review article

C2 - 17322002

AN - SCOPUS:36448935660

VL - 363

SP - 87

EP - 99

JO - Philosophical Transactions of the Royal Society B: Biological Sciences

JF - Philosophical Transactions of the Royal Society B: Biological Sciences

SN - 0800-4622

IS - 1489

ER -